home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

abnormal gene silencing may lead to breast cancer progression

 
  November, 17 2000 1:04
your information resource in human molecular genetics
 
     
Emory researchers report abnormal gene silencing may lead to breast cancer progression


Emory University scientists have discovered that a mistake in the way DNA is labeled and packaged by methyltransferase enzymes could lead to the abnormal silencing of TMS-1, a gene that plays an important role in keeping breast cancer cells in check, thus contributing to breast cancer progression.

Contact:
Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University Health Sciences Center


Message posted by: Wouter Kalle

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.